Lawsuit Alert: Geron Corporation Investors Notified of Class Action by Levi & Korsinsky

Geron Corporation investors have been notified of a class-action lawsuit by Levi & Korsinsky. The lawsuit pertains to allegations that Geron Corporation made misleading statements about the results of the IMbark Phase 2 study. This study evaluated imetelstat as a treatment for myelofibrosis. The lawsuit claims that the company failed to disclose that the study results were skewed due to a material change in the selection criteria for patients. This change allegedly made it easier for certain patients to enter the study.

Levi & Korsinsky announced the class-action lawsuit on behalf of investors who purchased Geron Corporation securities between March 19, 2018, and September 26, 2018. This lawsuit aims to recover financial losses suffered by investors due to the alleged misleading statements made by the company during this period.

Geron Corporation provides investors with the opportunity to sign on as a lead plaintiff in the class-action lawsuit. A lead plaintiff represents the class members and acts on their behalf throughout the legal process. Investors who feel that they meet the criteria for lead plaintiff status must take action before the deadline to participate in the class-action lawsuit.

Investors who wish to join the class-action lawsuit are encouraged to contact Levi & Korsinsky. The law firm will provide information on how to become a lead plaintiff and participate in the legal proceedings against Geron Corporation.

The class-action lawsuit against Geron Corporation highlights the importance of transparency and accuracy in providing information to investors. Misleading statements or omissions can have serious consequences for companies and their shareholders. Investors rely on accurate information to make informed decisions about their investments, and any discrepancies can lead to financial losses and legal action.

As the legal process unfolds, Geron Corporation will need to address the allegations made in the class-action lawsuit. The company’s response to these accusations will be closely scrutinized by investors and regulators. Transparency and accountability are crucial in maintaining investor confidence and trust in the company and its leadership.

In conclusion, the class-action lawsuit against Geron Corporation serves as a reminder of the potential consequences of misleading statements and omissions. Investors must have access to accurate and transparent information to make informed decisions about their investments. The outcome of this lawsuit will have implications for Geron Corporation and its shareholders, highlighting the importance of honesty and integrity in financial reporting.